Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
Study Information
Alliance Study ID: NCCTG-987251
NCT Study ID (ClinicalTrials.gov): NCT00003621
Disease or Cancer Type: Brain / Central Nervous System Cancer
Alliance Study Chair: Jan C. Buckner, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy in treating patients who have newly diagnosed anaplastic astrocytoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information